Free Radical-Mediated Molecular Damage
Mechanisms for the Protective Actions of Melatonin in the Central Nervous System
Corresponding Author
RUSSEL J. REITER
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Address for correspondence: Russel J. Reiter, Department of Cellular and Structural Biology, Mail Code 7762, The University of Texas Health Science Center At San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, U.S.A. Voice: 210/567-3859; fax: 210/567-6948; [email protected].Search for more papers by this authorDARIO ACUÑA-CASTROVIEJO
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Search for more papers by this authorDUN-XIAN TAN
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Search for more papers by this authorSUSANNE BURKHARDT
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Search for more papers by this authorCorresponding Author
RUSSEL J. REITER
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Address for correspondence: Russel J. Reiter, Department of Cellular and Structural Biology, Mail Code 7762, The University of Texas Health Science Center At San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, U.S.A. Voice: 210/567-3859; fax: 210/567-6948; [email protected].Search for more papers by this authorDARIO ACUÑA-CASTROVIEJO
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Search for more papers by this authorDUN-XIAN TAN
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Search for more papers by this authorSUSANNE BURKHARDT
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, U.S.A.
Search for more papers by this authorAbstract
Abstract: This review briefly summarizes the multiple actions by which melatonin reduces the damaging effects of free radicals and reactive oxygen and nitrogen species. It is well documented that melatonin protects macromolecules from oxidative damage in all subcellular compartments. This is consistent with the protection by melatonin of lipids and proteins, as well as both nuclear and mitochondrial DNA. Melatonin achieves this widespread protection by means of its ubiquitous actions as a direct free radical scavenger and an indirect antioxidant. Thus, melatonin directly scavenges a variety of free radicals and reactive species including the hydroxyl radical, hydrogen peroxide, singlet oxygen, nitric oxide, peroxynitrite anion, and peroxynitrous acid. Furthermore, melatonin stimulates a number of antioxidative enzymes including superoxide dismutase, glutathione peroxidase, glutathione reductase, and catalase. Additionally, melatonin experimentally enhances intracellular glutathione (another important antioxidant) levels by stimulating the rate-limiting enzyme in its synthesis, γ-glutamylcysteine synthase. Melatonin also inhibits the proxidative enzymes nitric oxide synthase and lipoxygenase. Finally, there is evidence that melatonin stabilizes cellular membranes, thereby probably helping them resist oxidative damage. Most recently, melatonin has been shown to increase the efficiency of the electron transport chain and, as a consequence, to reduce election leakage and the generation of free radicals. These multiple actions make melatonin a potentially useful agent in the treatment of neurological disorders that have oxidative damage as part of their etiological basis.
REFERENCES
- 1 Youdim, M.B.H., D. Ben-Shacbar, G. Eshel, et al. 1993. The neurotoxicity of iron and nitric oxide: relevance to the etiology of Parkinson's disease. Adv. Neurol. 60: 259–266.
- 2 Reiter, R.J. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9: 526–533.
- 3 Smith, M.A., G. Perry, P.L. Richey, et al. 1996. Oxidative damage in Alzheimer's. Nature 382: 120–121.
- 4 Dalkara, T. &M.A. Moschowitz. 1994. The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia. Brain Pathol. 4: 49–57.
- 5 Reiter, R.J. 1998. Oxidative damage in the central nervous system: Protection by melatonin. Prog. Neurobiol. 56: 359–384.
- 6 Hardeland, R., R.J. Reiter, B. Poeggeler & D.X. Tan, 1993. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci. Biobehav. Rev. 17: 347–357.
- 7 Blanchard, B., D. Pompon & C. Ducrocq, 2000. Nitrosation of melatonin by nitric oxide and peroxynitrite. J. Pineal Res. 29: 184–192.
- 8 Reiter, R.J. 2000. Melatonin: lowering the high price of free radicals. News Physiol. Sci. 15: 256–260.
- 9 Tan, D.X., L.D. Chen, B. Poeggeler, et al. 1993. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J. 1: 57–60.
- 10 Reiter, R.J., L. Tang, J.J. Garcia & A. Muñoz-Hoyos, 1997. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60: 2255–2271.
- 11 Tan, D.X., L.C. Manchester, R.J. Reiter, et al. 2000. Significance of melatonin in antioxidant defense system: reactions and products. Biol. Signals Recept. 9: 137–159.
- 12 Reiter, R.J., D.X. Tan, W. Qi, et al. 2000. Pharmacological and physiology of melatonin in the reduction of oxidative stress in vivo. Biol. Signals Recept. 9: 160–171.
- 13 Reiter, R.J., J.J. Garcia & J. Pie, 1998. Oxidative toxicity in models of neurodegeneration: responses to melatonin. Rest. Neurol. Neurosci. 12: 135–142.
- 14 Pappolla, M.A., Y.J. Chyan, B. Poeggeler, et al. 2000. An assessment of the antioxidant and antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural Transm. 107: 203–231.
- 15 Reiter, R.J., J. Cabrera, R.M. Sainz, et al. 1999. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and Parkinsonism. Ann. N.Y. Acad. Sci. 890: 471–484.
- 16 Tan, D.X., L.C. Manchester, W. Qi, et al. 1999. High physiological levels of melatonin in the bile of mammals. Life Sci. 65: 2523–2529.
- 17 Shiesh, S.C., C.Y. Chen, X.Z. Lin, et al. 2000. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepathology 32: 455–460.
- 18 Hedlund, L., M.M. Lischko, M.D. Rollag & G.D. Niswender, 1977. Melatonin: daily cycle in plasma and cerebrospinal fluid. Science 195: 686–687.
- 19 Kanematsu, N., Y. Mori, S. Hayashi & K. Hoshino, 1989. Presence of a distinct 24-hour melatonin rhythm in the ventricular spinal fluid of the goat. J. Pineal Res. 7: 143–152.
- 20 Skinner, D.C. &B. Malpaux. 1999. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 140: 4399–4405.
- 21 Huether, G., B. Poeggeler, A. Reiner & A. George, 1992. Effect of tryptophan administration on circulating melatonin levels in chicks and rats: Evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci. 51: 945–953.
- 22 Huether, G. 1993. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 48: 665–670.
- 23 Saarela, S., M. Vuori, E. Eloranta & O. Vakkuri, 1997. Melatonin, a candidate signalling molecule for energy sparing. Ornis Fenn. 76: 231–235.
- 24 Tan, D.X., L.C. Manchester, R.J. Reiter, et al. 1999. Identification of highly elevated levels of melatonin in bone marrow: Its origin and significance. Biochim. Biophys. Acta 1472: 206–214.
- 25 Conti, A., S. Coniconi, E. Herten, et al. 2000. Evidence for melatonin synthesis in mouse and human bone marrow. J. Pineal Res. 28: 193–202.
- 26 Bubenik, G.A. 1980. Localization of melatonin in the digestive tract of the rat. Effect of maturation, diurnal variation, melatonin treatment and pinealectomy. Horm. Res. 6: 313–323.
- 27 Kvetnoy, I. 1999. Extrapineal melatonin: Location and role within diffuse neuroendocrine system. Histochem. J. 31: 1–12.
- 28 Stefulj, J., M. Hoertner, M. Ghosh, et al. 2001. Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat. J. Pineal Res. 30: 243–247.
- 29 Menendez-Pelaez, A., B. Poeggeler, R.J. Reiter, et al. 1993. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 51: 373–382.
- 30 Menendez-Pelaez, A. &R.J. Reiter. 1993. Distribution of melatonin in mammalian tissues: the relative importance of nuclear verses cytosolic localization. J. Pineal Res. 15: 59–69.
- 31 Martin, M., M. Macias, G. Escames, et al. 2000. Melatonin but not vitamins C and E maintain glutathione homeostasis in t-butyl hydroperoxide-included mitochondrial oxidative stress. FASEB J. 14: 1677–1679.
- 32 Acuña-Castroviejo, D., M. Martin, M. Macias, et al. 2001. Melatonin, mitochondria and cellular bioenergetics. J. Pineal Res. 30: 65–74.
- 33 Lahiri, D.K. 1999. Melatonin affects metabolism of the β-amyloid precursor protein in different cell types. J. Pineal Res. 26: 137–146.
- 34 Poeggeler, B., S. Saarela, R.J. Reiter, et al. 1994. Melatonin—a highly potent endogenous radical scavenger and electron donor: new aspects of oxidation chemistry of this indole assessed in vitro. Ann. N.Y. Acad. Sci. 738: 419–420.
- 35 Poeggeler, B., R.J. Reiter, R. Hardeland, et al. 1996. Melatonin and structurally related endogenous indoles act as potent electron donors and free radical scavengers in vitro. Redox Rept. 2: 179–184.
- 36 Li, X.J., L.M. Zhang, J. Gu, et al. 1997. Melatonin decreases production of hydroxyl radical during ischemia-reperfusion. Acta Pharmacol. Sinica 18: 394–396.
- 37 Matuszek, Z., K.J. Reszka & C.F. Chignell, 1997. Reaction of melatonin and related indoles with hydroxyl radicals: ESR and spin trapping investigations. Free Rad. Biol. Med. 23: 267–272.
- 38 Susa, N., S. Ueno, Y. Furukawa, et al. 1997. Potent protective effect of melatonin on chromium(VI) induced DNA single strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 144: 373–384.
- 39 Pähkla, R., M. Zilmer, T. Kullisar & L. Rägo, 1998. Comparison of the antioxidant activity of melatonin and pinoline in vitro. J. Pineal Res. 24: 96–101.
- 40 Stasica, P., P. Ulanski & J.M. Rosiak, 1998. Melatonin as a hydroxyl radical scavenger. J. Pineal Res. 25: 65–66.
- 41 Stasica, P., P. Ulanski & J.M. Rosiak, 1998. Reaction of melatonin with radicals in deoxygenated aqueous solutions. J. Radioanal. Nucl. Chem. 232: 107–113.
- 42 Tan, D.X., L.C. Manchester, R.J. Reiter, et al. 1998. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem. Biophys. Res. Commun. 253: 614–620.
- 43 Chyan, Y.J., B. Poeggeler, R.A. Omar, et al. 1999. Potent neuroprotective properties against Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J. Biol. Chem. 274: 21937–21942.
- 44 Mahal, H.S., H.S. Sharma & T. Mukherjee, 1998. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radical Biol. Med. 26: 557–565.
- 45 Bandyopadhyay, D., K. Biswas, U. Bandyopadhyay, et al. 2000. Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical. J. Pineal Res. 25: 143–151.
- 46 Oosthuizen, M.M.J. &D. Greyling. 1999. Antioxidants suitable for use with chemiluminescence to identify oxyradical species. Redox Rept. 4: 277–290.
- 47 Brömme, H.J., W. Mörke, E. Peschke, et al. 2000. Scavenging effect of melatonin on hydroxyl radical generated by alloxan. J. Pineal Res. 29: 201–208.
- 48 Kaneko, S., K. Okumura, Y. Dumaguchi, et al. 2000. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemia reperfusion injury. Life Sci. 67: 101–112.
- 49 Khaldy, H., G. Escames, J. Leon, et al. 2000. Comparative effects of melatonin, l-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vivo. J. Pineal Res. 29: 100–107.
- 50 Reiter, R.J., D.X. Tan, L.C. Manchester & W. Qi. 2001. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem. Biophys, In press.
- 51 Zang, L.Y., G. Cosma, H. Gardner & V. Vallynathan, 1998. Scavenging of reactive oxygen species by melatonin. Biochim. Biophys. Acta 1425: 469–477.
- 52 Tan, D.X., L.C. Manchester, R.J. Reiter, et al. 2000. Melatonin directly scavenges hydrogen peroxide: A potentially new metabolic pathway of melatonin biotransformation. Free Radical Biol. Med. 29: 1177–1185.
- 53 Marshall, K.A., R.J. Reiter, B. Poeggeler, et al. 1996. Evaluation of the antioxidant activity of melatonin in vivo. Free Radical Biol. Med. 21: 307–315.
- 54 Chan, T.Y. &P.L. Tang. 1996. Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal Res. 20: 187–191.
- 55 Cagnoli, C.M., C. Atabay, E. Kharlamova & H. Manev, 1995. Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18: 222–226.
- 56 Noda, Y., A. Mori, R. Liburty & L. Packer, 1999. Melatonin and its precursors scavenge nitric oxide. J. Pineal Res. 27: 159–163.
- 57 Gilad, E., S. Cuzzocrea, B. Zingarelli, et al. 1997. Melatonin as a scavenger of peroxynitrite. Life Sci. 60: PL169–PL174.
- 58 Cuzzocrea, S., D.X. Tan, G. Costantino, et al. 1999. The protective role of melatonin in carrageen-induced pleurisy in rat. FASEB J. 13: 1930–1938.
- 59 El-Sokkary, G.H., R.J. Reiter, S. Cuzzocrea, et al. 1999. Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan. Shock 12: 402–408.
- 60 Zhang, H., G.L. Squadrito & W.A. Pryor, 1998. The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem. Biophys. Res. Commun. 251: 83–87.
- 61 Zhang, H., G.L. Squadrito, R. Uppi & W.A. Pryor, 1999. Reaction of peroxynitrite with melatonin: A mechanistic study. Chem. Res. Toxicol. 12: 526–534.
- 62 Livrea, M.A., L. Tesoriere, D.X. Tan & R.J. Reiter. 2001. Radical and reactive intermediate scavenging properties of melatonin in pure chemical systems. In Handbook of Antioxidants. E. Cardenas & L. Packer, Eds.: Marcell Dekker, New York, In press.
- 63 Qi, W., R.J. Reiter, D.X. Tan, et al. 2000. Increased levels of oxidatively damaged DNA induced by chromium (III) and H2O2: Protection by melatonin and related molecules. J. Pineal Res. 29: 54–61.
- 64 Pieri, C., F. Moroni, M. Marra, et al. 1995. Melatonin as an efficient antioxidant. Arch. Gerontol. Geriatrics 20: 159–165.
- 65 Antunes, F., L.R.C. Barclay, K.U. Ingold, et al. 1999. On the antioxidant activity of melatonin. Free Radical Biol. Med. 26: 117–128.
- 66 Cuzzocrea, S., G. Costantino, E. Gitto, et al. 2000. Protective effects of melatonin in ischemic brain injury. J. Pineal Res. 29: 217–227.
- 67 Ohta, Y., M. Kongo, E. Sasaki, et al. 2000. Protective effect of melatonin against a-naphthlisocyanate-induced liver injury in rats. J. Pineal Res. 29: 15–23.
- 68 Sailaja Devi, M.M., Y. Suresh & U.N. Das, 2000. Preservation of the antioxidant status in chemically induced diabetes mellitus by melatonin. J. Pineal Res. 29: 108–115.
- 69 Pablos, M.I., M.T. Agapito, R. Gutierrez, et al. 1995. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J. Pineal Res. 19: 111–115.
- 70 Antolin, I., C. Rodriquez, R.M. Sainz, et al. 1996. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidative enzymes. FASEB J. 10: 882–890.
- 71 Montilla Lopez, P., I. Tunez-Finaña, C. Muñoz de Agueda, et al. 2000. Protective effect of melatonin against oxidative stress induced by ligature of extra-hepatic biliary duct in rats: comparison with the effect of S-adenosyl-l-methionine. J. Pineal Res. 28: 143–149.
- 72 Pablos, M.I., R.J. Reiter, G.G. Ortiz, et al. 1998. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int. 32: 69–75.
- 73 Albarran, M.T., S. Lopez-Burillo, M.I. Pablos, et al. 2001. Endogenous rhythms of melatonin, total antioxidant status and superoxide dismutase activity in several tissues of chick and their inhibition by light. J. Pineal Res. 30: 227–233.
- 74 Urata, Y.S., S. Honma, S. Goto, et al. 1999. Melatonin induces γ-glutamylcysteine synthase mediated by activator protein-1 in human vascular endothelial cells. Free Rad. Biol. Med. 27: 838–847.
- 75 Carlberg, C. &I. Wiesenberg. 1995. The orphan receptor family RZR/ROR, melatonin and lipoxygenase: an unexpected relationship. J. Pineal Res. 18: 171–178.
- 76 Pozo, D., R.J. Reiter, J.M. Calvo & J.M. Guerrero, 1997. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem. 65: 430–432.
10.1002/(SICI)1097-4644(19970601)65:3<430::AID-JCB12>3.0.CO;2-J CASPubMedWeb of Science®Google Scholar
- 77 Gilad, E., H.R. Wong, B. Zingarelli, et al. 1998. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role in inhibition of NF-κB activation. FASEB J. 12: 685–693.
- 78 Garcia, J.J., R.J. Reiter, J.M. Guerrero, et al. 1997. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 408: 297–300.
- 79 Garcia, J.J., R.J. Reiter, J. Pie, et al. 1999. Role or pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J. Bioenerg. Biomembr. 31: 609–616.
- 80 Skulachev, P.C. 1999. Mitochondrial physiology and pathology: concepts of programmed death of organelles, cells and organisms. Mol. Aspects Med. 20: 139–184.
- 81 Susin, S.A., N. Zamzami & G. Kroemer, 1998. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1366: 151–165.
- 82 Nicholls, D.G. &S.L. Budd. 2000. Mitochondria and neuronal survival. Physiol. Rev. 80: 315–360.
- 83 Martin, M., M. Macias, G. Escames, et al. 2000. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J. Pineal Res. 28: 242–248.
- 84 Martin, M., M. Macias, G. Escames, et al. 2000. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J. 14: 1677–1679.
- 85 Livrea, M.A., L. Tesoriere, D. Arpa & M. Morreale, 1997. Reaction of melatonin with lipoperoxyl radicals in phospholipid biolayers. Free Rad. Biol. Med. 23: 706–711.
- 86 Reiter, R.J., D.X. Tan, S.J. Kim & W. Qi, 1998. Melatonin as a pharmacological agent against oxidative damage to lipids and DNA. Proc. West. Pharmacol. Soc. 41: 229–236.
- 87 Cuzzocrea, S., G. Costantino, E. Mazzon, et al. 2000. Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J. Pineal Res. 28: 52–63.
- 88 Acuña-Castroviejo, D., G. Escames, M. Macias, et al. 1995. Cell protective role of melatonin in the brain. J. Pineal Res. 19: 57–63.
- 89 Kim, S.J., R.J. Reiter, M.V. Rouvier-Garay, et al. 1998. Nitropropane-induced lipid peroxidation and DNA damage: Antitoxic effects of melatonin. Toxicology 130: 183–190.
- 90 Melchiorri, D., G.G. Ortiz, R.J. Reiter, et al. 1998. Melatonin reduces paraquat-induced genotoxicity in mice. Toxicol. Lett. 95: 103–108.
- 91 Qi, W., R.J. Reiter, D.X. Tan, et al. 2000. Increased levels of oxidatively damaged DNA induced by chromium (III) and H2O2: protection by melatonin and related indoles. J. Pineal Res. 29: 54–61.
- 92 Coto-Montes, A. &R. Hardeland. 1999. Antioxidative effects of melatonin in Drosophila melanogaster: antagonization of damage induced by the inhibition of catalase. J. Pineal Res. 27: 154–158.
- 93 Kim, S.J., R.J. Reiter, W. Qi, et al. 2000. Melatonin prevents oxidative damage to protein and lipid induced by ascorbate-Fe3+-EDTA: comparison with glutathione and α-tocopherol. Neuroendocrinol. Lett. 21: 269–276.
- 94 Ceraulo, L., M. Ferrugia, L. Tesoriere, et al. 1999. Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed micelles. J. Pineal Res. 26: 108–112.
- 95 Bolognan, C.V., M. Yamamoto, N. Takei, et al. 2000. Gial cell survival is enhanced during melatonin-induced neuroprotection against cerebral edema. FASEB J. 14: 1307–1317.
- 96 Seabra, M. de L.V., M. Bignotto, L.R. Pinto, Jr. & S. Tufik, 2000. Randomized, double blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J. Pineal Res. 29: 193–200.
- 97 Jan, J.E., D. Hamilton, N. Seward, et al. 2000. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J. Pineal Res. 29: 34–39.
- 98 Jahnke, G., M. Marr, C. Myers, et al. 1999. Maternal and developmental toxicity evaluation of melatonin administration orally to pregnant Sprague-Dawley rats. Toxicol. Res. 50: 271–279.
- 99 Brusco, L.I., M. Marquez & D.P. Cardinali, 1998. Monozygotic twins with Alzheimer's disease treated with melatonin: case report. J. Pineal Res. 25: 260–263.